miR-1297 promotes cell proliferation by inhibiting RB1 in liver cancer
Chengyong Liu1, Chunying Wang2, Ji Wang2
1Department of Clinical Laboratory, Xuzhou City Hospital For Infectious Diseases, Xuzhou, Jiangsu 221000, P.R. China.
Abstract:
Liver cancer is the one of the most common causes of cancer-associated mortality worldwide. MicroRNAs (miRNAs or miRs) are important in various types of cancer, including liver cancer. In the present study, with miRNA expression profile data obtained from the Gene Expression Omnibus database, three independent methods were used to investigate the miRNAs that are involved in liver carcinogenesis, including Fisher's exact test, t-test and Wilcoxon test. Five differentially expressed miRNAs were identified. Among them, miR-1297 drew specific attention. Target gene analysis and Ingenuity Pathway Analysis revealed its potential impact on cell death and cell cycle. Cell Counting Kit-8 proliferation assay indicated that the HepG2 cell proliferation was promoted by miR-1297, while miR-1297 inhibitor could significantly inhibit the proliferation of HepG2 cells. Luciferase assays confirmed that miR-1297 directly bound to the 3'-untranslated region of retinoblastoma (RB)1, and western blotting demonstrated that miR-1297 suppressed the expression of RB1 at the protein level. RB1 is involved in the regulation of the human cell cycle pathway. It is possible that miR-1297 contributes to the carcinogenesis of liver cancer via downregulation of the tumor-suppressor gene RB1. Our results suggest that miR-1297 may serve as a potential therapeutic target of liver cancer.
Insights
MicroRNAs (miRNAs) play a role in liver cancer. This study identified miR-1297 as a promoter of liver cancer by downregulating the tumor suppressor gene RB1, suggesting it as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Liver cancer is a leading cause of cancer mortality globally.
- MicroRNAs (miRNAs) are implicated in the development of various cancers, including liver cancer.
Purpose of the Study:
- To identify microRNAs involved in liver carcinogenesis.
- To investigate the role of miR-1297 in liver cancer development and its molecular mechanisms.
Main Methods:
- Analysis of miRNA expression profile data from the Gene Expression Omnibus database.
- Utilized Fisher's exact test, t-test, and Wilcoxon test for differential expression analysis.
- Performed cell proliferation assays (Cell Counting Kit-8), luciferase assays, and western blotting.
Main Results:
- Identified five differentially expressed miRNAs, with miR-1297 showing significant involvement.
- miR-1297 promoted HepG2 cell proliferation and directly targeted the 3'-untranslated region of retinoblastoma 1 (RB1).
- miR-1297 suppressed RB1 protein expression, impacting cell cycle regulation.
Conclusions:
- miR-1297 may contribute to liver carcinogenesis by downregulating the tumor suppressor gene RB1.
- miR-1297 represents a potential therapeutic target for liver cancer treatment.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
MicroRNAs


